Sunday, 5 December, 2021
E-paper

Eskayef, Square receive DGDA approval to produce Covid-19 drug molnupiravir

  • Sun Online Desk
  • 9th November, 2021 06:48:27 PM
  • Print news
Eskayef, Square receive DGDA approval to produce Covid-19 drug molnupiravir

Popular News

The Directorate General of Drug Administration (DGDA) has given production and marketing authorisation for the  Covid-19 drug molnupiravir to two pharmaceutical companies Eskayef and Square in the country.

DGDA Director General Major General Mahbubur Rahman shared the development at a press briefing at noon today.

Earlier in the day, Beximco Pharmaceuticals Ltd got the marketing authorisation from the DGDA.

In addition, there are some other pharmaceutical companies on the approval list, according to DGDA director.